what's better tirzepatide or semaglutide vs for weight loss what's better wegovy or tirzepatide

Abstract Tirzepatide, a dual agonist for glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, has shown robust efficacy in treating diabetes and obesity, and in obese patients with heart failure with preserved ejection fraction (HFpEF), it reduced weight, lowered blood pressure, and improved outcomes

Indeed, the inhibition of GT or cysteine S -conjugate -lyase (both highly expressed in proximal tubule cells of the kidney) blocks the nephrotoxicity of cisplatin in mice (Townsend et al., 2003)

(PubMed) Riggs KM, Spiro A, 3rd, Tucker K, Rush D

For more information, visit www.HavasHealth.com